Publication | Closed Access

Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E2-cypionate: effects on ovarian function

ContraceptionMedroxyprogesterone AcetateHormonal ContraceptiveFertilityReproductive HealthPharmacologyGynecologyDelayed First InjectionHormonal Male ContraceptionMenstrual CyclePublic HealthOvarian FunctionMedicineWomen's HealthOvarian Cancer